Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Oral ICP-488 in Moderate-to-Severe Plaque Psoriasis
CTR20250582Phase 3Active
- Sponsor
- Innovent Biologics
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of icp-488 in plaque psoriasis, psoriasis, sponsored by Innovent Biologics. Started Mar 2025; status: active.
02
Drugs
icp-488
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on CTR20250582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250582.